Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathoracic endostar with or without cisplatin for malignant pleural effusion
ChiCTR-IPR-16008803Phase 4Not yet recruiting
- Sponsor
- Chongqing University Cancer Hospital
- Start
- Aug 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in malignant pleural effusion (MPE) and bronchial carcinoma comparing Endostar monotherapy group, Endostar combined cisplatin group and Cisplatin monotherapy group (3 arms). Primary endpoint: Objective response rate. Planned start Aug 2016; status: not yet recruiting.
02
Drugs
endostarcisplatin
03
Conditions
malignant pleural effusion (MPE)bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR-IPR-16008803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008803.